Press Release Details
Colfax Reports Fourth Quarter and Full Year 2010 Results and Announces Acquisition of Rosscor Holding B.V.
Fourth quarter of 2010 (all comparisons versus the fourth quarter of 2009)
- Net income of
$8.7 million (20 cents per share — basic and diluted); adjusted net income (as defined below) of$16.9 million (39 cents per share), an increase of 47.1% - Net sales of
$166.7 million , an increase of 27.2%; organic sales increase (as defined below) of 27.4% - Operating income of
$19.6 million ; adjusted operating income (as defined below) of$26.5 million , an increase of 42.0%. - Fourth quarter orders of
$133.6 million , an increase of 31.5%; organic order growth (as defined below) of 34.4% - Backlog of
$313.5 million at period end
Full year 2010 (all comparisons versus full year 2009)
- Net income of
$16.2 million (37 cents per share — basic and diluted); adjusted net income (as defined below) of$40.2 million (92 cents per share), a decrease of 1.7% - Net sales of
$542.0 million , an increase of 3.2%; organic sales increase (as defined below) of 3.1% - Operating income of
$34.4 million ; adjusted operating income (as defined below) of$65.8 million , a decrease of 2.3%. - Orders for the year of
$532.8 million , an increase of 15.2%; organic order growth (as defined below) of 15.4% - Net working capital was reduced by
$18 million in 2010 and is now 19% of sales
Additionally, Colfax announced the acquisition of
Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.
"We are continuing to gain traction with our strategic priorities, including intensifying the application of the Colfax Business System, the development of new Voice of the Customer-aligned products and the realignment into a global market-facing organization. We are also continuing to build our leadership team, and are delighted to welcome
Mr. Kiefaber also noted the importance of Rosscor's MPP expertise and experience to Colfax's portfolio of leading global brands. "Rosscor was one of the first to introduce MPP technology nearly twenty years ago, and has remained a technology leader since then," he said. "With more than 70 MPP installations world-wide, Rosscor brings us deep capabilities in MPP that we can leverage through our existing channels."
Non-GAAP Financial Measures and Other Adjustments
Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, earnings before interest, taxes and depreciation (EBITDA), adjusted EBITDA, organic sales growth, organic order growth and projected adjusted net income per share. Adjusted net income, adjusted net income per share, adjusted EBITDA and adjusted operating income exclude asbestos liability and defense costs (income) and asbestos coverage litigation expenses, and restructuring and other related charges to the extent they impact the periods presented. Adjusted net income, adjusted net income per share and projected adjusted net income per share present income taxes at an effective tax rate of 32%. Projected adjusted net income per share excludes estimated restructuring and other related charges, asbestos coverage litigation expenses and asbestos liability and defense costs. Organic sales growth and organic order growth exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of legacy asbestos issues and items outside the control of its operating management team.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release
Colfax defines net working capital as trade receivables, less allowance for doubtful accounts, and inventories, net less accounts payable.
Conference Call and Webcast
Colfax will host a conference call to provide details about its results and outlook on
About
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by
Colfax Corporation | |||||||||
Condensed Consolidated Statements of Operations | |||||||||
Dollars in thousands, except per share data | |||||||||
(Unaudited) | |||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||
2010 | 2009 | 2010 | 2009 | ||||||
Net sales | $166,651 | $130,971 | $541,987 | $525,024 | |||||
Cost of sales | 107,077 | 83,960 | 350,579 | 339,237 | |||||
Gross profit | 59,574 | 47,011 | 191,408 | 185,787 | |||||
Selling, general and administrative expenses | 31,597 | 27,028 | 119,426 | 112,503 | |||||
Research and development expenses | 1,474 | 1,320 | 6,205 | 5,930 | |||||
Restructuring and other related charges | 808 | 7,420 | 10,323 | 18,175 | |||||
Asbestos liability and defense costs (income) | 3,697 | (1,017) | 7,876 | (2,193) | |||||
Asbestos coverage litigation expenses | 2,443 | 2,904 | 13,206 | 11,742 | |||||
Operating income | 19,555 | 9,356 | 34,372 | 39,630 | |||||
Interest expense | 1,609 | 1,746 | 6,684 | 7,212 | |||||
Income before income taxes | 17,946 | 7,610 | 27,688 | 32,418 | |||||
Provision for income taxes | 9,296 | 884 | 11,473 | 8,621 | |||||
Net income | $ 8,650 | $ 6,726 | $ 16,215 | $ 23,797 | |||||
Net income per share—basic | $ 0.20 | $ 0.16 | $ 0.37 | $ 0.55 | |||||
Net income per share—diluted | $ 0.20 | $ 0.15 | $ 0.37 | $ 0.55 | |||||
Colfax Corporation | ||||||
Condensed Consolidated Balance Sheets | ||||||
Dollars in thousands | ||||||
(Unaudited) | ||||||
December 31, | ||||||
2010 | 2009 | |||||
ASSETS | ||||||
CURRENT ASSETS: | ||||||
Cash and cash equivalents | $ 60,542 | $ 49,963 | ||||
Trade receivables, less allowance for doubtful accounts | 98,070 | 88,493 | ||||
Inventories, net | 57,941 | 71,150 | ||||
Asbestos insurance asset | 34,117 | 31,502 | ||||
Asbestos insurance receivable | 46,108 | 35,891 | ||||
Other current assets | 24,278 | 20,649 | ||||
Total current assets | 321,056 | 297,648 | ||||
Deferred income taxes, net | 52,385 | 51,838 | ||||
Property, plant and equipment, net | 89,246 | 92,090 | ||||
Goodwill and intangible assets, net | 200,636 | 175,370 | ||||
Long-term asbestos insurance asset | 340,234 | 357,947 | ||||
Long-term asbestos insurance receivable | 5,736 | 16,876 | ||||
Deferred loan costs and other assets | 12,784 | 14,532 | ||||
Total assets | $ 1,022,077 | $ 1,006,301 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||
CURRENT LIABILITIES: | ||||||
Current portion of long-term debt and capital leases | $ 10,000 | $ 8,969 | ||||
Accounts payable | 50,896 | 36,579 | ||||
Accrued asbestos liability | 37,875 | 34,866 | ||||
Other accrued liabilities | 92,739 | 70,685 | ||||
Total current liabilities | 191,510 | 151,099 | ||||
Long-term debt, less current portion | 72,500 | 82,516 | ||||
Long-term asbestos liability | 391,776 | 408,903 | ||||
Pension and accrued post-retirement benefits | 112,257 | 105,230 | ||||
Other liabilities | 37,663 | 41,728 | ||||
Total liabilities | 805,706 | 789,476 | ||||
Shareholder's equity | 216,371 | 216,825 | ||||
Total liabilities and shareholders' equity | $ 1,022,077 | $ 1,006,301 | ||||
Colfax Corporation | |||||
Condensed Consolidated Statement of Cash Flows | |||||
Dollars in thousands | |||||
(Unaudited) | |||||
Year ended December 31, | |||||
2010 | 2009 | ||||
Cash flows from operating activities: | |||||
Net income | $ 16,215 | $ 23,797 | |||
Adjustments to reconcile net income to cash provided by operating activities: | |||||
Depreciation, amortization and fixed asset impairment charges | 16,130 | 15,074 | |||
Noncash stock-based compensation | 3,137 | 2,593 | |||
Other adjustments for non-cash items | 767 | 613 | |||
Deferred income taxes | (296) | 2,689 | |||
Changes in working capital | 27,297 | 6,144 | |||
Changes in other operating assets and liabilities | (1,285) | (12,206) | |||
Net cash provided by operating activities | 61,965 | 38,704 | |||
Cash flows from investing activities: | |||||
Purchases of fixed assets | (12,527) | (11,006) | |||
Acquisitions, net of cash received | (27,960) | (1,678) | |||
Proceeds from sale of fixed assets | 74 | 219 | |||
Net cash used in investing activities | (40,413) | (12,465) | |||
Cash flows from financing activities: | |||||
Payments under term credit facility | (8,750) | (5,000) | |||
Proceeds from borrowings on revolving credit facilities | 5,500 | - | |||
Repayments of borrowings on revolving credit facilities | (5,500) | - | |||
Other | 707 | (417) | |||
Net cash used in financing activities | (8,043) | (5,417) | |||
Effect of exchange rates on cash | (2,930) | 379 | |||
Increase in cash and cash equivalents | 10,579 | 21,201 | |||
Cash and cash equivalents, beginning of year | 49,963 | 28,762 | |||
Cash and cash equivalents, end of year | $ 60,542 | $ 49,963 | |||
Colfax Corporation | |||||||||
Reconciliation of GAAP to non-GAAP Financial Measures | |||||||||
Dollars in thousands, except share data | |||||||||
(Unaudited) | |||||||||
Three Months Ended | Year Ended | ||||||||
2010 | 2009 | 2010 | 2009 | ||||||
EBITDA | |||||||||
Net income | $ 8,650 | $ 6,726 | $ 16,215 | $ 23,797 | |||||
Interest expense | 1,609 | 1,746 | 6,684 | 7,212 | |||||
Provision for income taxes | 9,296 | 884 | 11,473 | 8,621 | |||||
Depreciation and amortization | 4,888 | 3,834 | 16,130 | 14,426 | |||||
EBITDA | $ 24,443 | $ 13,190 | $ 50,502 | $ 54,056 | |||||
EBITDA margin | 14.7% | 10.1% | 9.3% | 10.3% | |||||
Adjusted EBITDA | |||||||||
Net income | $ 8,650 | $ 6,726 | $ 16,215 | $ 23,797 | |||||
Interest expense | 1,609 | 1,746 | 6,684 | 7,212 | |||||
Provision for income taxes | 9,296 | 884 | 11,473 | 8,621 | |||||
Depreciation and amortization | 4,888 | 3,834 | 16,130 | 14,426 | |||||
Restructuring and other related charges | 808 | 7,420 | 10,323 | 18,175 | |||||
Asbestos liability and defense costs (income) | 3,697 | (1,017) | 7,876 | (2,193) | |||||
Asbestos coverage litigation expenses | 2,443 | 2,904 | 13,206 | 11,742 | |||||
Adjusted EBITDA | $ 31,391 | $ 22,497 | $ 81,907 | $ 81,780 | |||||
Adjusted EBITDA margin | 18.8% | 17.2% | 15.1% | 15.6% | |||||
Adjusted Net Income and Adjusted Earnings per Share | |||||||||
Net income | $ 8,650 | $ 6,726 | $ 16,215 | $ 23,797 | |||||
Restructuring and other related charges | 808 | 7,420 | 10,323 | 18,175 | |||||
Asbestos liability and defense costs (income) | 3,697 | (1,017) | 7,876 | (2,193) | |||||
Asbestos coverage litigation expenses | 2,443 | 2,904 | 13,206 | 11,742 | |||||
Tax adjustment to effective rate of 32% | 1,330 | (4,529) | (7,437) | (10,624) | |||||
Adjusted net income | $ 16,928 | $ 11,504 | $ 40,183 | $ 40,897 | |||||
Adjusted net income margin | 10.2% | 8.8% | 7.4% | 7.8% | |||||
Weighted average shares outstanding - diluted | 43,876,791 | 43,449,493 | 43,667,225 | 43,325,704 | |||||
Adjusted net income per share | $ 0.39 | $ 0.26 | $ 0.92 | $ 0.94 | |||||
Net income per share—diluted | |||||||||
in accordance with GAAP | $ 0.20 | $ 0.15 | $ 0.37 | $ 0.55 | |||||
Adjusted Operating Income | |||||||||
Operating income | $ 19,555 | $ 9,356 | $ 34,372 | $ 39,630 | |||||
Restructuring and other related charges | 808 | 7,420 | 10,323 | 18,175 | |||||
Asbestos liability and defense costs (income) | 3,697 | (1,017) | 7,876 | (2,193) | |||||
Asbestos coverage litigation expenses | 2,443 | 2,904 | 13,206 | 11,742 | |||||
Adjusted operating income | $ 26,503 | $ 18,663 | $ 65,777 | $ 67,354 | |||||
Adjusted operating income margin | 15.9% | 14.2% | 12.1% | 12.8% | |||||
Colfax Corporation | |||||||||
Change in Sales and Orders | |||||||||
Dollars in millions | |||||||||
(Unaudited) | |||||||||
Sales | Orders | ||||||||
$ | % | $ | % | ||||||
Three Months Ended December 31, 2009 | $ 131.0 | $ 101.6 | |||||||
Components of Change: | |||||||||
Existing Businesses | 36.0 | 27.4 % | 35.0 | 34.4 % | |||||
Acquisitions | 5.4 | 4.1 % | 1.3 | 1.3 % | |||||
Foreign Currency Translation | (5.7) | (4.3)% | (4.3) | (4.2)% | |||||
Total | 35.7 | 27.2 % | 32.0 | 31.5 % | |||||
Three Months Ended December 31, 2010 | $ 166.7 | $ 133.6 | |||||||
Sales | Orders | Backlog at | |||||||
$ | % | $ | % | $ | % | ||||
Year ended December 31, 2009 | $ 525.0 | $ 462.4 | $ 290.9 | ||||||
Components of Change: | |||||||||
Existing Businesses | 16.1 | 3.1 % | 71.1 | 15.4 % | (6.6) | (2.3)% | |||
Acquisitions | 10.0 | 1.9 % | 6.1 | 1.3 % | 38.7 | 13.3 % | |||
Foreign Currency Translation | (9.1) | (1.7)% | (6.8) | (1.5)% | (9.5) | (3.3)% | |||
Total | 17.0 | 3.2 % | 70.4 | 15.2 % | 22.6 | 7.8 % | |||
Year ended December 31, 2010 | $ 542.0 | $ 532.8 | $ 313.5 | ||||||
SOURCE
News Provided by Acquire Media